Document is current
Any future updates will be listed below
-
Authors
,
Deeks, Steven G https://orcid.org/0000-0001-6371-747X
Lewin, Sharon R
Ross, Anna Laura
Ananworanich, Jintanat
Benkirane, Monsef
Cannon, Paula
Chomont, Nicolas
Douek, Daniel
Lifson, Jeffrey D
Lo, Ying-Ru
Kuritzkes, Daniel
Margolis, David https://orcid.org/0000-0001-5714-0002
Mellors, John
Persaud, Deborah
Tucker, Joseph D
Barre-Sinoussi, Françoise
Alter, Galit
Auerbach, Judith
Autran, Brigitte
Barouch, Dan H
Behrens, Georg
Cavazzana, Marina
Chen, Zhiwei
Cohen, Éric A
Corbelli, Giulio Maria
Eholié, Serge
Eyal, Nir
Fidler, Sarah
Garcia, Laurindo
Grossman, Cynthia
Henderson, Gail
Henrich, Timothy J
Jefferys, Richard
Kiem, Hans-Peter
McCune, Joseph
Moodley, Keymanthri
Newman, Peter A
Nijhuis, Monique
Nsubuga, Moses Supercharger
Ott, Melanie
Palmer, Sarah
Richman, Douglas
Saez-Cirion, Asier
Sharp, Matthew
Siliciano, Janet
Silvestri, Guido
Singh, Jerome
Spire, Bruno
Taylor, Jeffrey
Tolstrup, Martin
Valente, Susana
van Lunzen, Jan
Walensky, Rochelle
Wilson, Ira
Zack, Jerome
- License Information
-
More Information
Article History
Received: 25 February 2016
Accepted: 12 April 2016
First Online: 11 July 2016
Competing interests
: S.G.D. has received research funding and support from Gilead Sciences, Merck and ViiV, and consulting fees from Bristol-Myers Squibb, Bionor and InVirVax. J.V.L. is a full-time employee of ViiV Healthcare, a company developing and distributing antiretroviral drugs. J.W.M. is a consultant to Gilead Sciences, has received research funding from Gilead Sciences and Bristol-Myers Squibb and owns shares in Co-Crystal Pharma, Inc. D.M.M. has received research funding from Gilead Sciences, Bristol-Myers Squibb and Qura Therapeutics, consulting fees from Merck Research Laboratories, and owns common stock in Gilead Sciences A.S.-C. reports a grant from MSD, consultancy honoraria from ViiV healthcare, lecture honoraria from MSD, Gilead and Bristol-Myers Squibb. S.R.L.'s institution receives funding for investigator-initiated studies from Merck, Gilead Sciences, Viiv and Tetralogic pharmaceuticals. She has received consulting fees from and is on the advisory board of Bionor and honoraria for educational activities from Viiv and Merck.
